Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

HIV reservoirs: what, where and how to target them


One of the main challenges in the fight against HIV infection is to develop strategies that are able to eliminate the persistent viral reservoir that harbours integrated, replication-competent provirus within host cellular DNA. This reservoir is resistant to antiretroviral therapy (ART) and to clearance by the immune system of the host; viruses originating from this reservoir lead to rebound viraemia once treatment is stopped, giving rise to new rounds of infection. Several studies have focused on elucidating the cells and tissues that harbour persistent virus, the true size of the reservoir and how best to target it, but these topics are the subject of ongoing debate. In this Viewpoint article, several experts in the field discuss the constitution of the viral reservoir, how best to measure it and the best ways to target this source of persistent infection.

This is a preview of subscription content

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Soriano-Sarabia, N. et al. Peripheral Vγ9Vδ2 T cells are a novel reservoir of latent HIV infection. PLoS Pathog. 11, e1005201 (2015).

    Article  Google Scholar 

  2. 2

    Churchill, M. J. et al. Use of laser capture microdissection to detect integrated HIV-1 DNA in macrophages and astrocytes from autopsy brain tissues. J. Neurovirol. 12, 146–152 (2006).

    Article  Google Scholar 

  3. 3

    Johnson, T. P. et al. Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein. Proc. Natl Acad. Sci. USA 110, 13588–13593 (2013).

    CAS  Article  Google Scholar 

  4. 4

    Canestri, A. et al. Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy. Clin. Infect. Dis. 50, 773–778 (2010).

    Article  Google Scholar 

  5. 5

    Dahl, V. et al. An example of genetically distinct HIV type 1 variants in cerebrospinal fluid and plasma during suppressive therapy. J. Infect. Dis. 209, 1618–1622 (2014).

    Article  Google Scholar 

  6. 6

    Peluso, M. J. et al. Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load. AIDS 26, 1765–1774 (2012).

    CAS  Article  Google Scholar 

  7. 7

    Crooks, A. M. et al. Precise quantitation of the latent HIV-1 reservoir: implications for eradication strategies. J. Infect. Dis. 212, 1361–1365 (2015).

    CAS  Article  Google Scholar 

  8. 8

    Churchill, M. J. et al. Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia. Ann. Neurol. 66, 253–258 (2009).

    Article  Google Scholar 

  9. 9

    Glass, J. D., Fedor, H., Wesselingh, S. L., McArthur, J. C. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann. Neurol. 38, 755–762 (1995).

    CAS  Article  Google Scholar 

  10. 10

    Gray, L. R. et al. CNS-specific regulatory elements in brain-derived HIV-1 strains affect responses to latency-reversing agents with implications for cure strategies. Mol. Psychiatry, (2015).

Download references

Author information



Corresponding authors

Correspondence to Melissa J. Churchill, Steven G. Deeks, David M. Margolis, Robert F. Siliciano or Ronald Swanstrom.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Churchill, M., Deeks, S., Margolis, D. et al. HIV reservoirs: what, where and how to target them. Nat Rev Microbiol 14, 55–60 (2016).

Download citation

Further reading


Quick links